BIOSPHINGS AG has a total of 22 patent applications. Its first patent ever was published in 2001. It filed its patents most often in WIPO (World Intellectual Property Organization), Germany and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and macromolecular chemistry and polymers are BIOSUCCESS BIOTECH CO LTD, NEUROTECH PHARMACEUTICALS CO LTD and INST MEDIZINTECHNOLOGIE MAGDEB.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Germany | 5 | |
#3 | China | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Australia | 1 | |
#6 | Canada | 1 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Polysaccharides |
# | Name | Total Patents |
---|---|---|
#1 | Amtmann Eberhard | 18 |
#2 | Eberhard Amtmann | 4 |
Publication | Filing date | Title |
---|---|---|
WO2009074305A1 | Gold xanthogenates and medicaments comprising them | |
DE102006014390A1 | Composition, useful in medicament to treat e.g. Alzheimer's disease, viral-, tumor, cardiovascular- and autoimmune diseases, and in chemical synthesis e.g. to synthesize xanthogenate metal complexes, comprises a xanthogenate compound | |
DE10343365A1 | Pharmaceutical Formulations of Xanthogenates and Inhibitors of Viral Nucleic Acid Replication | |
DE10156617A1 | Preparation of pure stereoisomers of tricyclo [5.2.1.0 ·· 2 ··. ·· 6 ··] -dec-9-yl-xanthate and medicinal products therefrom | |
DE10149919A1 | New carboxylic acid salts of guanidine derivatives useful as sphingomyelinase inhibitors for treating e.g. tumor, cardiovascular or viral diseases | |
DE10117728A1 | Pharmaceutical formulations for xanthates |